This multi-dimensional therapeutic potential is reshaping the positioning of GLP-1 drugs as comprehensive metabolic treatments rather than just glucose-lowering agents For instance, Novo Nordisks semaglutide is now marketed as Wegovy specifically for chronic weight management, while Eli Lillys tirzepatide has received FDA approval under the brand name Zepbound for obesity treatment, independent of diabetic status
More specifically: For compound lifts (squats, deadlifts, presses, rows): 3-4 sets of 6-10 reps at a weight that leaves 1-2 reps in reserve
Why are we still in need of novel anti-obesity medications
Healthy mitochondrial function is vital for healthy aging.5
Ipamorelin selectively binds to the GHSR-1a receptor, another G protein-coupled receptor involved in growth hormone regulation
As research progresses, GLP-1 will likely become an integral part of weight loss plans